Gyre Therapeutics (GYRE) Change in Account Payables (2014 - 2026)
Gyre Therapeutics (GYRE) reported Change in Account Payables of $139000.0 for Q1 2026, up 892.86% year-over-year from $14000.0 in Q1 2025, and up 131.1% on a QoQ basis from -$447000.0 in Q4 2025.
Gyre Therapeutics (GYRE) has 13 years of Change in Account Payables data on file, last reported at $139000.0 in Q1 2026.
- Quarterly Change in Account Payables rose 892.86% year-over-year to $139000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $124000.0 (up 159.62% YoY) and the FY2025 annual result came in at -$1000.0, up 99.59% from the prior year.
- Change in Account Payables rose to $139000.0 in Q1 2026 per GYRE's latest filing, from -$447000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $6.3 million in Q4 2022 and bottomed at -$3.7 million in Q2 2022.
- The 5-year median for Change in Account Payables is -$23000.0 (2024), against an average of -$1588.2.
- The widest annual swing landed in 2022, when Change in Account Payables sank 227.01%; it then soared 1625.0% in 2025.
- Tracing GYRE's Change in Account Payables over 5 years: stood at $6.3 million in 2022, then sank by 105.38% to -$337000.0 in 2023, then surged by 43.62% to -$190000.0 in 2024, then sank by 135.26% to -$447000.0 in 2025, then surged by 131.1% to $139000.0 in 2026.
- Per Business Quant, the three latest GYRE Change in Account Payables figures stand at $139000.0 (Q1 2026), -$447000.0 (Q4 2025), and $483000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn | 139,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 139,000.00 |
| Mar 31, 2026 | 139,000.00 |
| Dec 31, 2025 | -447,000.00 |
| Dec 31, 2025 | -447,000.00 |
| Sep 30, 2025 | 483,000.00 |
| Sep 30, 2025 | 483,000.00 |
| Jun 30, 2025 | -51,000.00 |
| Jun 30, 2025 | -51,000.00 |
| Mar 31, 2025 | 14,000.00 |
| Mar 31, 2025 | 14,000.00 |
| Dec 31, 2024 | -190,000.00 |
| Dec 31, 2024 | -190,000.00 |
| Sep 30, 2024 | 28,000.00 |
| Sep 30, 2024 | 28,000.00 |
| Jun 30, 2024 | -60,000.00 |
| Jun 30, 2024 | -60,000.00 |
| Mar 31, 2024 | -23,000.00 |
| Mar 31, 2024 | -23,000.00 |
| Dec 31, 2023 | -337,000.00 |
| Dec 31, 2023 | -337,000.00 |
| Sep 30, 2023 | 3,000.00 |
| Sep 30, 2023 | 3,000.00 |
| Jun 30, 2023 | 370,000.00 |
| Jun 30, 2023 | 370,000.00 |
| Mar 31, 2023 | 156,000.00 |
| Mar 31, 2023 | 156,000.00 |
| Dec 31, 2022 | 6.27 Mn |
| Dec 31, 2022 | 6.27 Mn |
| Sep 30, 2022 | -996,000.00 |
| Sep 30, 2022 | -996,000.00 |
| Jun 30, 2022 | -3.67 Mn |
| Jun 30, 2022 | -3.67 Mn |
| Mar 31, 2022 | -1.71 Mn |
| Mar 31, 2022 | -1.71 Mn |
| Dec 31, 2021 | 2.56 Mn |
| Dec 31, 2021 | 2.56 Mn |
| Sep 30, 2021 | 2.03 Mn |
| Sep 30, 2021 | 2.03 Mn |
| Jun 30, 2021 | -1.12 Mn |
| Jun 30, 2021 | -1.12 Mn |
| Mar 31, 2021 | -2.97 Mn |
| Mar 31, 2021 | -2.97 Mn |
| Dec 31, 2020 | 1.69 Mn |
| Dec 31, 2020 | 1.69 Mn |
| Sep 30, 2020 | 2.75 Mn |
| Sep 30, 2020 | 2.75 Mn |
| Jun 30, 2020 | 183,000.00 |
| Jun 30, 2020 | 183,000.00 |
| Mar 31, 2020 | -2.96 Mn |
| Mar 31, 2020 | -2.96 Mn |
| Dec 31, 2019 | 2.16 Mn |
| Dec 31, 2019 | 2.16 Mn |
| Sep 30, 2019 | 1.73 Mn |
| Sep 30, 2019 | 1.73 Mn |
| Jun 30, 2019 | 111,000.00 |
| Jun 30, 2019 | 111,000.00 |
| Mar 31, 2019 | -966,000.00 |
| Mar 31, 2019 | -966,000.00 |
| Dec 31, 2018 | 878,000.00 |
| Dec 31, 2018 | 878,000.00 |
| Sep 30, 2018 | 235,000.00 |
| Sep 30, 2018 | 235,000.00 |
| Jun 30, 2018 | -1.30 Mn |
| Jun 30, 2018 | -1.30 Mn |
| Mar 31, 2018 | 690,000.00 |
| Mar 31, 2018 | 690,000.00 |
| Dec 31, 2017 | -713,000.00 |
| Dec 31, 2017 | -713,000.00 |
| Sep 30, 2017 | 959,000.00 |
| Sep 30, 2017 | 959,000.00 |
| Jun 30, 2017 | -398,000.00 |
| Jun 30, 2017 | -398,000.00 |
| Mar 31, 2017 | 62,000.00 |
| Mar 31, 2017 | 62,000.00 |
| Dec 31, 2016 | 308,000.00 |
| Dec 31, 2016 | 308,000.00 |
| Sep 30, 2016 | -297,000.00 |
| Sep 30, 2016 | -297,000.00 |
| Jun 30, 2016 | 109,000.00 |
| Jun 30, 2016 | 109,000.00 |
| Mar 31, 2016 | -222,000.00 |
| Mar 31, 2016 | -222,000.00 |
| Dec 31, 2015 | 270,000.00 |
| Dec 31, 2015 | 270,000.00 |
| Sep 30, 2015 | -5.84 Mn |
| Sep 30, 2015 | -5.84 Mn |
| Jun 30, 2015 | 724,000.00 |
| Jun 30, 2015 | 724,000.00 |
| Mar 31, 2015 | 568,000.00 |
| Mar 31, 2015 | 568,000.00 |
| Dec 31, 2014 | 118,000.00 |
| Dec 31, 2014 | 118,000.00 |